Search Login Register
Channelopathies
Summary
Description:
A variety of neuromuscular conditions resulting from MUTATIONS in ION CHANNELS manifesting as episodes of EPILEPSY; HEADACHE DISORDERS; and DYSKINESIAS.
Also Known As:
Channelopathy
Networked: 710
relevant articles (15 outcomes,
42 trials/studies)
for this Disease
Key Drugs and Agents for Channelopathies
Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
-
Sodium
:
2 outcomes 8 studies in 127 results
: IBA
-
Potassium
:
2 outcomes 3 studies in 65 results
: IBA
-
Mexiletine (Mexitil)
:
2 outcomes 1 study in 2 results
:
FDA 5
Generic
-
Anticonvulsants (Antiepileptic Drugs)
:
2 outcomes in 3 results
: IBA
-
Ion Channels (Ion Channel)
:
1 outcome 11 studies in 199 results
: IBA
-
Calcium
:
1 outcome 4 studies in 75 results
: IBA
-
Sodium Channels (Sodium Channel)
:
1 outcome 4 studies in 61 results
: IBA
-
Calcium Channels (Calcium Channel)
:
1 outcome 3 studies in 31 results
: IBA
-
Nondystrophic myotonia
:
1 outcome 1 study in 1 result
: IBA
-
Acetazolamide (Diamox)
:
1 outcome in 4 results
:
FDA 13
Generic
Show All >>
Diseases Related to Channelopathies
-
Epilepsy (Aura)
-
Paralysis (Palsy)
-
Myotonia
-
Hypokalemic Periodic Paralysis (Periodic Paralysis, Hypokalemic)
-
Ataxia (Dyssynergia)
Show All >>
Key Therapies for Channelopathies
Efficacy Chart >>
-
Implantable Defibrillators (Implantable Cardioverter-Defibrillator)
:
1 outcome 1 study in 15 results
-
Tenotomy
:
1 outcome in 1 result
-
Thyroidectomy
:
1 outcome in 1 result
-
Denervation
:
1 outcome in 1 result
-
Drug Therapy (Chemotherapy)
:
6 results
Show All >>
CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.